NMR-determined lipoprotein subclass profile predicts type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 83, Issue 1, 2009, Pages 132-139

  Hodge, Allison M ^a   Jenkins, Alicia J ^a   English, Dallas R ^a,b   O'Dea, Kerin ^a   Giles, Graham G ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

Author keywords

Diabetes mellitus; Lipoproteins; Magnetic resonance spectroscopy; Predictive studies; Type 2

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; FACTORIAL ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE; PARTICLE SIZE; PHYSICIAN; PREDICTION; PREDICTOR VARIABLE; REGRESSION ANALYSIS; RISK FACTOR;

ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIPOPROTEINS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED;

EID: 57949090863     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.11.007     Document Type: Article

References (25)

1. Jeyarajah E.J., Cromwell W.C., and Otvos J.D. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin. Lab. Med. 26 (2006) 847-870
2. Austin M.A., Mykkanen L., Kuusisto J., Edwards K.L., Nelson C., Haffner S., et al. Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women. Circulation 92 (1995) 1770-1778
3. Freedman D.S., Otvos J.D., Jeyarajah E.J., Barboriak J.J., Anderson A.J., and Walker J.A. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1046-1053
4. Kathiresan S., Otvos J.D., Sullivan L.M., Keyes M.J., Schaefer E.J., Wilson P.W., et al. Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation 113 (2006) 20-29
5. Kuller L.H., Grandits G., Cohen J.D., Neaton J.D., and Prineas R. Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome. Atherosclerosis 195 (2007) 122-128
6. El Harchaoui K., van der Steeg W.A., Stroes E.S., Kuivenhoven J.A., Otvos J.D., Wareham N.J., et al. Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. J. Am. Coll. Cardiol. 49 (2007) 547-553
7. Garvey W.T., Kwon S., Zheng D., Shaughnessy S., Wallace P., Hutto A., et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 52 (2003) 453-462
8. Festa A., Williams K., Hanley A.J., Otvos J.D., Goff D.C., Wagenknecht L.E., et al. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study. Circulation 111 (2005) 3465-3472
9. Dunstan D., Zimmet P.Z., Welborn T.A., de Courten M.P., Cameron C.A., Sicree R., et al. The rising prevalence of diabetes and impaired glucose tolerance: The Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 25 (2002) 829-834
10. Giles G.G., and English D.R. The Melbourne Collaborative Cohort Study. In: Riboli E., and Lambert R. (Eds). Nutrition and Lifestyle: Opportunities for Cancer Prevention (2002), International Agency for Research on Cancer, Lyon 69-70
11. Jenkins A.J., Lyons T.J., Zheng D., Otvos J.D., Lackland D.T., McGee D., et al. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. Diabetes Care 26 (2003) 810-818
12. MacInnis R.J., English D.R., Hopper J.L., Haydon A.M., Gertig D.M., and Giles G.G. Body size and composition and colon cancer risk in men. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 553-559
13. National Health Medical Research Council. Australian Alcohol Guidelines: Health Risks and Benefits (2001), Commonwealth of Australia, Canberra
14. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J. Clin. Endocrinol. Metab. 85 (2000) 2402-2410
15. The Expert, Committee on the Diagnosis and Classification of Diabetes Mellitus, Report of the expert committee on the diagnosis and classification of diabetes mellitus, Diabetes Care, 20 (1997) 1183-1197.
16. Newby P.K., and Tucker K.L. Empirically derived eating patterns using factor or cluster analysis: a review. Nutr. Rev. 62 (2004) 177-203
17. Goff Jr. D.C., D'Agostino Jr. R.B., Haffner S.M., and Otvos J.D. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism 54 (2005) 264-270
18. Hu F.B., Stampfer M.J., Haffner S.M., Solomon C.G., Willett W.C., and Manson J.E. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 25 (2002) 1129-1134
19. Cnop M., Hannaert J.C., Grupping A.Y., and Pipeleers D.G. Low density lipoprotein can cause death of islet beta-cells by its cellular uptake and oxidative modification. Endocrinology 143 (2002) 3449-3453
20. Abderrahmani A., Niederhauser G., Favre D., Abdelli S., Ferdaoussi M., Yang J.Y., et al. Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells. Diabetologia 50 (2007) 1304-1314
21. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metforming. N.E. J. Med 346 (2002) 393-403
22. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., et al. Prevention of type 2 diabetes mellitus by change in lifestyle among subjects with impaired glucose tolerance. N. Eng. J. Med. 344 (2001) 1343-1350
23. Yuan G., Al-Shali K.Z., and Hegele R.A. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ 176 (2007) 1113-1120
24. Padwal R., Majumdar S.R., Johnson J.A., Varney J., and McAlister F.A. A systematic review of drug therapy to delay or prevent type 2 diabetes. Diabetes Care 28 (2005) 736-744
25. Kouris-Blazos A. Morbidity mortality paradox of 1st generation Greek Australians. Asia Pac. J. Clin. Nutr. 11 Suppl 3 (2002) S569-S575